Maternal Inflammation Alters Nuclear and Mitochondrial DNA Methylation Patterns in Neonatal Brain Monocytes
Cells · 18.04.2026 · 15 (8) · 714
DOI: 10.3390/cells15080714 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 18.04.2026. Verfasst von Andrew T Ebenezer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Nemours Children's Hospital, Wilmington, DE 19803, USA. Hauptthemen laut MEDLINE: DNA Methylation, DNA, Mitochondrial, Brain, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Nemours Foundation, Thomas Jefferson University.
Abstract (Originalsprache)
Neonatal hypoxic ischemic encephalopathy (HIE) is a common birth complication that can cause death or lifelong disabling conditions like cerebral palsy, epilepsy, and autism. It is well established that maternal infection and inflammation are significant risk factors for HIE but reasons for this increase in neurological risk to the offspring remain unknown. Inflammation or infection are associated with epigenetic changes and may contribute to the increased risk of neurodevelopmental disability in exposed offspring. Here, we analyzed and compared DNA methylation patterns in brain monocytes isolated from control, maternal immune activation (MIA), and an inflammation sensitized HIE (IS-HIE) CF-1 mouse model at postnatal day 7. We found that maternal inflammation induced significant methylation differences in neonates relative to control samples in both MIA and IS-HIE samples with no significant differences identified between the MIA and IS-HIE groups. MIA samples showed hypermethylation at loci involving craniofacial development and transcription factors important for regulating neurodevelopment and immune function. MIA samples also demonstrated significant hypermethylation at multiple mitochondrial genome CpGs. These findings suggest that maternal inflammation induces epigenetic alterations in fetal brain immune cells that are detectable in neonates. These changes may contribute to heightened neurodevelopmental risk in offspring following hypoxic injury, highlighting potential molecular pathways for future therapeutic targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurology, Nemours Children's Hospital, Wilmington, DE 19803, USA.
- Division of Biomedical Research, Nemours Children's Health, Wilmington, DE 19803, USA.
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- Medical and Molecular Sciences, University of Delaware, Newark, DE 19707, USA.
- Delaware Data Science Institute, Center for Bioinformatics and Computational Biology, University of Delaware, Newark, DE 19716, USA.
- School of Marine Science and Policy, University of Delaware, Newark, DE 19107, USA.
ORCID-Profile: Jonathan R Hicks, Mona Batish, Robert Akins, Elizabeth Wright-Jin
Förderung
- NIGMS NIH HHS
- Nemours Foundation
- Thomas Jefferson University
- NIH
Zitieren
APA
Ebenezer, A. T., Hicks, J. R., Hollander, B., Hone, A., Batish, M., Akins, R., Marsh, A., & Wright-Jin, E. (2026). Maternal Inflammation Alters Nuclear and Mitochondrial DNA Methylation Patterns in Neonatal Brain Monocytes. Cells, 15(8), 714. https://doi.org/10.3390/cells15080714
Vancouver
Ebenezer AT, Hicks JR, Hollander B, Hone A, Batish M, Akins R, et al. Maternal Inflammation Alters Nuclear and Mitochondrial DNA Methylation Patterns in Neonatal Brain Monocytes. Cells. 2026;15(8):714. doi:10.3390/cells15080714
BibTeX
@article{Ebenezer2026,
author = {Ebenezer, Andrew T and Hicks, Jonathan R and Hollander, Brooke and Hone, Alexander and Batish, Mona and Akins, Robert and Marsh, Adam and Wright-Jin, Elizabeth},
title = {Maternal Inflammation Alters Nuclear and Mitochondrial DNA Methylation Patterns in Neonatal Brain Monocytes},
journal = {Cells},
year = {2026},
volume = {15},
number = {8},
pages = {714},
doi = {10.3390/cells15080714}
}
EUVIMED